Abstract

The reconstitution of the T-cell repertoire and quantity is a major challenge in the clinical management of HIV infection/AIDS, cancer, and aging-associated diseases. We previously showed that autologous bone marrow transfusion (BMT) via the hepatic portal vein could effectively restore CD4+ T-cell count in AIDS patients also suffering from decompensated liver cirrhosis. In the current study, we characterized T-cell reconstitution in a mouse model of liver fibrosis induced by CCl4 and found that T-cell reconstitution after BMT via hepatic portal vein was also greatly enhanced. The expression of Dll4 (Delta-like 4), which plays an important role in T-cell progenitor expansion, was elevated in hepatocytes of fibrotic livers when compared to normal livers. This upregulation of Dll4 expression was found to be induced by TNFα in an NFκB-dependent manner. Liver fibroblasts transfected with Dll4 (LF-Dll4) also gained the capacity to promote T-cell lineage development from hematopoietic stem cells (HSCs), resulting in the generation of DN2 (CD4 and CD8 DN 2) and DN3 T-cell progenitors in vitro, which underwent a normal maturation program when adoptively transferred into Rag-2 deficient hosts. We also demonstrated a pivotal role of SDF-1 produced by primary liver fibroblasts (primary LF) in T-lineage differentiation from HSCs. These results suggest that Dll4 and SDF-1 in fibrotic liver microenvironment could promote extrathymic T-cell lineage development. These results expand our knowledge of T-cell development and reconstitution under pathological conditions.

Details

Title
Fibrotic liver microenvironment promotes Dll4 and SDF-1-dependent T-cell lineage development
Author
Gong, Zheng 1 ; Shang Bingxue 2 ; Chu Yunpeng 2 ; Chen, Xiaodong 3 ; Li, Qing 3 ; Liu, Keli 3 ; Chen Yongjing 2 ; Huang, Yin 3   VIAFID ORCID Logo  ; Han, Yanyan 3 ; Shang Qianwen 2 ; Zheng Zhiyuan 2 ; Song, Lin 2 ; Li, Yanan 2 ; Liu, Rui 2 ; Xu Chenchang 2 ; Zhang Xiaoren 3 ; Liu, Baochi 4 ; Wang, Luowei 5 ; Shao Changshun 2   VIAFID ORCID Logo  ; Wang, Ying 3 ; Shi, Yufang 1   VIAFID ORCID Logo 

 Soochow University Medical College, The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694); University of Chinese Academy of Sciences, Key Laboratory of Tissue Microenvironment and Tumor, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 Soochow University Medical College, The First Affiliated Hospital of Soochow University, Institutes for Translational Medicine, State Key Laboratory of Radiation Medicine and Protection, Key Laboratory of Stem Cells and Medical Biomaterials of Jiangsu Province, Suzhou, China (GRID:grid.263761.7) (ISNI:0000 0001 0198 0694) 
 University of Chinese Academy of Sciences, Key Laboratory of Tissue Microenvironment and Tumor, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 Shanghai Public Health Clinical Center Fudan University, Department of Surgery, Shanghai, China (GRID:grid.470110.3) (ISNI:0000 0004 1770 0943) 
 Changhai Hospital, Second Military Medical University, Department of Gastroenterology, Shanghai, China (GRID:grid.411525.6) (ISNI:0000 0004 0369 1599) 
Publication year
2019
Publication date
Jun 2019
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2235657450
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.